Literature DB >> 24179731

Increased levels of interleukins 2 and 17 in the cerebrospinal fluid of patients with idiopathic intracranial hypertension.

Laura J Edwards1, Basil Sharrack, Azza Ismail, Christopher R Tench, Bruno Gran, Samish Dhungana, Johannes Brettschneider, Hayrettin Tumani, Cris S Constantinescu.   

Abstract

IIH is a condition of raised intracranial pressure of unknown pathogenesis, which is most commonly seen in young overweight women. This study was designed to confirm and extend previous reports by our and other groups showing increased inflammatory cytokine expression in patients with IIH. We analyzed the concentrations of 14 cytokines (IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, IL-17, IL-22, IL-23, IFNγ, TNFα, TGFβ, and osteopontin) in the serum and cerebrospinal fluid (CSF) of 17 patients with IIH and 53 patients with other neurological conditions. Patients with IIH had highly elevated IL-2, IL-4, IL-10, IL-17 and IFNγ in the CSF compared to patients with multiple sclerosis or non-organic/non-inflammatory neurological conditions. No significant differences were seen between serum cytokine levels in four patient groups (IIH - multiple sclerosis - inflammatory neurological conditions - non-organic/non-inflammatory neurological conditions) and there were no correlations between serum and CSF cytokine levels. In IIH, levels of IL-2, IL-8 and IL-17 were significantly higher in CSF than serum; levels of IL-1β, IL-4, IL-22, IFNγ and TNFα were significantly higher in serum than CSF. For most cytokines, the CSF/serum cytokine ratio was significantly higher than the CSF/serum albumin ratio, indicating intrathecal synthesis of these cytokines in IIH. We conclude that IIH is associated with elevated levels of IL-17 and IL-2 in the CSF, suggesting the involvement of these cytokines in disease pathogenesis.

Entities:  

Keywords:  Cerebrospinal fluid; cytokines; idiopathic intracranial hypertension; serum

Year:  2013        PMID: 24179731      PMCID: PMC3808932     

Source DB:  PubMed          Journal:  Am J Clin Exp Immunol


  46 in total

Review 1.  Pathways and mechanisms for cytokine signaling of the central nervous system.

Authors:  J Licinio; M L Wong
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

2.  Transverse sinus stenoses persist after normalization of the CSF pressure in IIH.

Authors:  F Bono; C Giliberto; C Mastrandrea; D Cristiano; A Lavano; F Fera; A Quattrone
Journal:  Neurology       Date:  2005-10-11       Impact factor: 9.910

3.  Thrombin potently stimulates cytokine production in human vascular smooth muscle cells but not in mononuclear phagocytes.

Authors:  R Kranzhöfer; S K Clinton; K Ishii; S R Coughlin; J W Fenton; P Libby
Journal:  Circ Res       Date:  1996-08       Impact factor: 17.367

Review 4.  Interventions for idiopathic intracranial hypertension.

Authors:  C Lueck; G McIlwaine
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

5.  Effect of liposuction on insulin resistance and vascular inflammatory markers in obese women.

Authors:  G Giugliano; G Nicoletti; E Grella; F Giugliano; K Esposito; N Scuderi; F D'Andrea
Journal:  Br J Plast Surg       Date:  2004-04

6.  Enhanced production of IL-17A during zymosan-induced peritonitis in obese mice.

Authors:  Maria Pini; Giamila Fantuzzi
Journal:  J Leukoc Biol       Date:  2009-09-10       Impact factor: 4.962

7.  Effect of weight loss on cardiac synchronization and proinflammatory cytokines in premenopausal obese women.

Authors:  Raffaele Marfella; Katherine Esposito; Mario Siniscalchi; Federico Cacciapuoti; Francesco Giugliano; Domenico Labriola; Myriam Ciotola; Carmen Di Palo; Lucio Misso; Dario Giugliano
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

8.  Epidemiology of idiopathic intracranial hypertension: a prospective and case-control study.

Authors:  K Radhakrishnan; A K Thacker; N H Bohlaga; J C Maloo; S E Gerryo
Journal:  J Neurol Sci       Date:  1993-05       Impact factor: 3.181

9.  Modulation of endothelial cell hemostatic properties by tumor necrosis factor.

Authors:  P P Nawroth; D M Stern
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

10.  Idiopathic intracranial hypertension: the association between weight loss and the requirement for systemic treatment.

Authors:  Roger Wong; Stephen A Madill; Pravin Pandey; Paul Riordan-Eva
Journal:  BMC Ophthalmol       Date:  2007-09-21       Impact factor: 2.209

View more
  16 in total

Review 1.  Current concepts and strategies in the diagnosis and management of idiopathic intracranial hypertension in adults.

Authors:  Jane W Chan
Journal:  J Neurol       Date:  2017-01-31       Impact factor: 4.849

2.  Glial and neuronal antibodies in patients with idiopathic intracranial hypertension.

Authors:  Güneş Altıokka-Uzun; Ece Erdağ; Betül Baykan; John Tzartos; Duygu Gezen-Ak; Bedia Samancı; Erdinç Dursun; Paraskevi Zisimopoulou; Katerina Karagiorgou; Christos Stergiou; Erdi Şahin; Esme Ekizoğlu; Murat Kürtüncü; Erdem Tüzün
Journal:  Neurol Sci       Date:  2017-07-21       Impact factor: 3.307

3.  Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma.

Authors:  Felicitas Strehlow; Sandra Bauer; Peter Martus; Michael Weller; Patrick Roth; Uwe Schlegel; Sabine Seidel; Carmen Scheibenbogen; Agnieszka Korfel; Stephan Kreher
Journal:  J Neurooncol       Date:  2016-06-13       Impact factor: 4.130

4.  Cerebrospinal Fluid IL-17A Could Predict Acute Disease Severity in Non-NMDA-Receptor Autoimmune Encephalitis.

Authors:  Michael Levraut; Véronique Bourg; Nicolas Capet; Adrien Delourme; Jérôme Honnorat; Pierre Thomas; Christine Lebrun-Frenay
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

5.  A complex role of herpes viruses in the disease process of multiple sclerosis.

Authors:  Simone C Wuest; Ina Mexhitaj; Noo Ri Chai; Elena Romm; Joerg Scheffel; Biying Xu; Kelly Lane; Tianxia Wu; Bibiana Bielekova
Journal:  PLoS One       Date:  2014-08-22       Impact factor: 3.240

Review 6.  Idiopathic intracranial hypertension: ongoing clinical challenges and future prospects.

Authors:  Parunyou Julayanont; Amputch Karukote; Doungporn Ruthirago; Deepa Panikkath; Ragesh Panikkath
Journal:  J Pain Res       Date:  2016-02-19       Impact factor: 3.133

Review 7.  Idiopathic intracranial hypertension, hormones, and 11β-hydroxysteroid dehydrogenases.

Authors:  Keira A Markey; Maria Uldall; Hannah Botfield; Liam D Cato; Mohammed A L Miah; Ghaniah Hassan-Smith; Rigmor H Jensen; Ana M Gonzalez; Alexandra J Sinclair
Journal:  J Pain Res       Date:  2016-04-19       Impact factor: 3.133

8.  Osmolality of Cerebrospinal Fluid from Patients with Idiopathic Intracranial Hypertension (IIH).

Authors:  Elisabeth A Wibroe; Hanne M Yri; Rigmor H Jensen; Morten A Wibroe; Steffen Hamann
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

Review 9.  Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis.

Authors:  Elmira Agah; Arshia Zardoui; Amene Saghazadeh; Mona Ahmadi; Abbas Tafakhori; Nima Rezaei
Journal:  PLoS One       Date:  2018-01-18       Impact factor: 3.240

10.  Increased intracranial pressure in Guillain-Barré syndrome: A case report.

Authors:  Pan-Pan Zhao; Qian-Kun Ji; Rui-Bin Sui; Rong Zhang; Li-Jun Zhang; Zhi-Xiu Xu; Qing Li; Si-Bei Ji; Jian-Hua Zhao
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.